BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND Neurokinin
17 results:

  • 1. Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients with pancreatic cancer: a retrospective cohort study.
    Hishida-Sadaka S; Iihara H; Ohata K; Matsuoka S; Watanabe D; Iwashita T; Uemura S; Shimizu M; Suzuki A
    Support Care Cancer; 2023 Oct; 31(12):657. PubMed ID: 37884842
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of Aprepitant on Etoposide Pharmacokinetics in Patients with Testicular cancer: A Pharmacokinetic Study to Determine the Absence of a Clinically Relevant Interaction.
    Strik J; de Jong LAW; Sijm J; Desar IME; van Erp NP
    Clin Pharmacol Ther; 2024 Jan; 115(1):135-138. PubMed ID: 37867292
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Effect of Blocking neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian cancer Cells.
    AlAlikhan A; Ghahremanloo A; Javid H; Ebrahimi S; Hashemy SI
    Cell Biochem Biophys; 2022 Dec; 80(4):819-827. PubMed ID: 36197642
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A Substance P (SP)/neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic cancer and Is Affected by lncRNA LOC389641.
    Ji T; Ma K; Wu H; Cao T
    J Immunol Res; 2022; 2022():5582811. PubMed ID: 35600049
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors.
    Tran CG; Sherman SK; Scott AT; Ear PH; Chandrasekharan C; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
    Ann Surg Oncol; 2021 Feb; 28(2):732-741. PubMed ID: 32656719
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The substance P and neurokinin-1 receptor system in human thyroid cancer: an immunohistochemical study.
    Isorna I; Esteban F; Solanellas J; Coveñas R; Muñoz M
    Eur J Histochem; 2020 Apr; 64(2):. PubMed ID: 32363847
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells.
    Huang C; Li Y; Guo Y; Zhang Z; Lian G; Chen Y; Li J; Su Y; Li J; Yang K; Chen S; Su H; Huang K; Zeng L
    Theranostics; 2018; 8(11):3074-3086. PubMed ID: 29896303
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk.
    Sinha S; Fu YY; Grimont A; Ketcham M; Lafaro K; Saglimbeni JA; Askan G; Bailey JM; Melchor JP; Zhong Y; Joo MG; Grbovic-Huezo O; Yang IH; Basturk O; Baker L; Park Y; Kurtz RC; Tuveson D; Leach SD; Pasricha PJ
    Cancer Res; 2017 Apr; 77(8):1868-1879. PubMed ID: 28386018
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pancreastatin predicts survival in neuroendocrine tumors.
    Sherman SK; Maxwell JE; O'Dorisio MS; O'Dorisio TM; Howe JR
    Ann Surg Oncol; 2014 Sep; 21(9):2971-80. PubMed ID: 24752611
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Involvement of substance P and the NK-1 receptor in pancreatic cancer.
    Muñoz M; Coveñas R
    World J Gastroenterol; 2014 Mar; 20(9):2321-34. PubMed ID: 24605029
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Rethinking the stalk effect: a new hypothesis explaining suprasellar tumor-induced hyperprolactinemia.
    Skinner DC
    Med Hypotheses; 2009 Mar; 72(3):309-10. PubMed ID: 19028420
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut.
    Ardill JE; Erikkson B
    Endocr Relat Cancer; 2003 Dec; 10(4):459-62. PubMed ID: 14713258
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid.
    Hanna FW; Ardill JE; Johnston CF; Cunningham RT; Curry WJ; Russell CF; Buchanan KD
    J Endocrinol; 1997 Feb; 152(2):275-81. PubMed ID: 9071985
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Gastrointestinal hormone profile in medullary thyroid carcinoma].
    Wirth HP; Eberle C; Meyenberger C; Bertschinger P; Häcki WH; Ammann R; Heitz PU
    Schweiz Med Wochenschr; 1994 May; 124(21):906-11. PubMed ID: 8016606
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Characterization of the C-terminal flanking peptide of human beta-preprotachykinin.
    McGregor GP; Conlon JM
    Peptides; 1990; 11(5):907-10. PubMed ID: 2284201
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. neurokinin B in a human pheochromocytoma measured with a specific radioimmunoassay.
    Kage R; Conlon JM
    Peptides; 1989; 10(3):713-6. PubMed ID: 2780425
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Post-translational processing of preprotachykinins. Isolation of protachykinin-(1-37)-peptide from human adrenal-medullary phaeochromocytoma tissue.
    Kage R; Thim L; Creutzfeldt W; Conlon JM
    Biochem J; 1988 Jul; 253(1):203-7. PubMed ID: 3421942
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.